Familial Combined Hyperlipidemia (FCH)
What is Familial Combined Hyperlipidemia (FCH)?
Familial Combined Hyperlipidemia, or FCH, is a genetic condition that causes high levels of fats in your blood. These fats include cholesterol and triglycerides, which are both types of lipids your body needs but can be harmful in excess. FCH is one of the most common inherited lipid disorders, affecting about 1 in 100 people.
People with FCH produce too many lipid-carrying particles in their liver. This leads to elevated levels of LDL cholesterol, the type often called bad cholesterol, and sometimes high triglycerides too. The pattern can vary even within the same family. Some family members may have mainly high cholesterol while others have mainly high triglycerides.
FCH significantly increases your risk of early heart disease and heart attacks. The condition often goes undetected until routine blood work reveals abnormal lipid levels. Unlike some genetic lipid disorders, FCH typically does not cause visible physical signs. Early detection through blood testing is essential for preventing cardiovascular problems down the road.
Symptoms
- No symptoms in most cases, especially early on
- Chest pain or pressure if heart disease develops
- Shortness of breath during physical activity
- Fatigue or weakness
- Fatty deposits around eyes, called xanthelasma, in some people
- Pancreatitis symptoms if triglycerides get very high, including severe stomach pain
Most people with FCH feel completely normal and have no symptoms until cardiovascular disease develops. This makes regular blood testing critical for early detection. Some people only discover they have FCH after a family member is diagnosed or after experiencing a heart-related event.
Concerned about Familial Combined Hyperlipidemia (FCH)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
FCH is caused by genetic mutations that affect how your body produces and processes lipids. The condition runs in families and follows a pattern called autosomal dominant inheritance. This means if one parent has FCH, each child has a 50 percent chance of inheriting it. However, the exact genes involved can vary, and researchers are still identifying all the genetic factors that contribute to FCH.
While genetics set the stage, lifestyle factors heavily influence how severe your lipid levels become. Being overweight or obese, eating a diet high in saturated fats and refined carbohydrates, lack of physical activity, and insulin resistance all make FCH worse. Type 2 diabetes, metabolic syndrome, and excessive alcohol use can also worsen lipid levels. Some medications like beta blockers and diuretics may raise triglycerides in people with FCH. Stress and smoking further increase cardiovascular risk in people with this condition.
How it's diagnosed
FCH is diagnosed through blood tests that measure your lipid levels and lipid-carrying particles. A standard lipid panel shows your total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. However, the hallmark test for FCH is Apolipoprotein B, or Apo B, which measures the number of lipid-carrying particles in your blood. Elevated Apo B is the most reliable marker for diagnosing FCH and distinguishing it from other lipid disorders.
Your doctor will also review your family history, looking for patterns of high cholesterol, early heart disease, or heart attacks in close relatives. Rite Aid offers Apo B testing as an add-on to help detect and monitor FCH. Testing at least one first-degree relative, like a parent or sibling, can help confirm the diagnosis. Regular monitoring helps track how well treatment is working over time.
Treatment options
- Adopt a heart-healthy diet rich in vegetables, fruits, whole grains, and lean proteins
- Reduce saturated fats found in red meat, butter, and full-fat dairy products
- Limit refined carbohydrates and added sugars that raise triglycerides
- Increase physical activity to at least 150 minutes of moderate exercise per week
- Lose weight if overweight, as even 5 to 10 percent weight loss improves lipid levels
- Avoid excessive alcohol, which raises triglycerides
- Quit smoking to reduce overall cardiovascular risk
- Statins are the first-line medication to lower LDL cholesterol and Apo B levels
- Fibrates or omega-3 fatty acids may be added if triglycerides remain high
- PCSK9 inhibitors or other advanced medications for people who need additional LDL lowering
- Regular follow-up with your doctor to monitor lipid levels and adjust treatment
Need testing for Familial Combined Hyperlipidemia (FCH)? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
FCH is a genetic condition that runs in families and typically causes high levels of both cholesterol and triglycerides from a young age. Regular high cholesterol is often caused mainly by lifestyle factors and develops later in life. FCH carries a higher risk of early heart disease and requires more aggressive treatment. Elevated Apolipoprotein B levels help doctors distinguish FCH from other lipid problems.
Your doctor will look at several factors including your lipid panel results, Apo B levels, age when high lipids first appeared, and family history. If you have high cholesterol or triglycerides at a young age and multiple family members with similar problems or early heart disease, FCH is more likely. Genetic testing is available but not always necessary for diagnosis.
FCH cannot be cured because it is a genetic condition. However, it can be very effectively managed with lifestyle changes and medication. Treatment aims to lower your lipid levels to reduce your risk of heart disease. With proper management, many people with FCH live long, healthy lives without cardiovascular problems.
Apolipoprotein B, or Apo B, is a protein found on lipid-carrying particles in your blood. Each harmful lipid particle contains exactly one Apo B molecule, so measuring Apo B tells you how many of these particles you have. In FCH, Apo B levels are typically elevated and provide a more accurate picture of cardiovascular risk than cholesterol alone.
Yes, first-degree relatives like parents, siblings, and children should all get tested. FCH is inherited, so there is a 50 percent chance that each of your close relatives also has it. Early detection allows family members to start preventive measures before heart disease develops. Testing should include a lipid panel and Apo B measurement.
Weight loss has the most significant impact if you are overweight. Even losing 5 to 10 percent of your body weight can improve lipid levels substantially. Regular exercise, reducing saturated fats and refined carbohydrates, and quitting smoking are also critical. These lifestyle changes work best when combined with medication in most cases.
Most people with FCH need lifelong medication because the condition is genetic and does not go away. However, aggressive lifestyle changes may reduce the dose you need. Never stop medication without talking to your doctor, as this can cause lipid levels to rise quickly and increase heart disease risk.
After diagnosis, your doctor will likely check your lipid levels every 3 to 6 months until they are well controlled. Once stable on treatment, annual testing is usually sufficient. Your doctor may recommend more frequent testing if medications are changed or if your weight or health status changes significantly.
Yes, FCH can affect children and often shows up in teenage years or early adulthood. Children with a parent who has FCH should be screened starting around age 10. Early detection allows for lifestyle interventions during crucial developmental years. Medication is sometimes needed in children with very high lipid levels or strong family histories of early heart disease.
Untreated FCH significantly increases your risk of developing heart disease at a young age, often in your 40s or 50s. High lipid levels cause plaque buildup in arteries, leading to heart attacks and strokes. The good news is that treatment dramatically reduces this risk. Early diagnosis and consistent management are key to preventing serious cardiovascular events.